A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD
Clinical trial NCT05297292 · UNKNOWN
Trial details
- NCT number
- NCT05297292
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-07
- Primary completion
- 2023-05-15
- Enrollment
- 433
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.